Last reviewed · How we verify

NCT03093935: PSSP

StimRouter™ for Pain Management in Post-stroke Shoulder Pain

Terminated NA Last updated 6 January 2021
What this trial tests

NA trial testing StimRouter Neuromodulation System in Chronic Pain in 6 participants. Terminated before completion.

Timeline
1 July 2018
Primary endpoint
20 November 2020
20 November 2020

Quick facts

Lead sponsorBioness Inc
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment6
Start date1 July 2018
Primary completion20 November 2020
Estimated completion20 November 2020
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Bioness Inc

Who can join

18 and older, any sex, with Chronic Pain or Hemiplegic Shoulder Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

StimRouter Neuromodulation System includes an implanted lead which provides peripheral nerve stimulation for chronic pain. Post-stroke shoulder pain patients will be the focus of this study. After meeting inclusion/exclusion criteria, approximately 50 enrolled patients will participate in the study through 6 months of follow-up. Various measures will be used to assess patient response to use of the device.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of StimRouter Neuromodulation System

Trials testing the same drug.

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

Other Bioness Inc trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03093935.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing